EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spinal Implant–Associated Infection in Type 2 and Type 1 Diabetes: Phenotype‐Specific Inflammatory Features and Therapeutic Response to Semaglutide

Thomas E Olson iD, Trevor S Lloyd, Christopher D Hamad, Rene F Chun, Joshua Wiener, Autreen Golzar, Joshua Mehany, Soroush Shahamatdar, Andrew Kittredge, Lauren Pearce, Kevin P Francis, Farres Obeidin und 5 weitere

JOR SPINE · 2026-06 · 9 (2)

DOI: 10.1002/jsp2.70196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JOR SPINE, online erschienen am 28.05.2026. Verfasst von Thomas E Olson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery David Geffen School of Medicine at UCLA Santa Monica California USA. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus (DM) is a major risk factor for postoperative infection and wound complications in spine surgery, yet distinctions between Type 2 (T2DM) and Type 1 (T1DM) pathophysiology are rarely addressed. This study compares infectious burden, wound healing, and immune response among a murine model of spinal implant‐associated infection of T2DM, T1DM, and nondiabetic control mice before and after metabolic intervention with the GLP‐1 receptor agonist (GLP‐1RA), semaglutide.

Methods

Male C57BL/6J mice were rendered diabetic by streptozotocin induction (T1DM) or a high‐fat, high‐sucrose diet (T2DM). Spinal implants were placed and inoculated with bioluminescent Staphylococcus aureus . Infection progression was monitored longitudinally by in vivo bioluminescence imaging. Systemic inflammation was characterized through multiplex cytokine profiling, and paraspinal tissues were analyzed by histology and multiplex immunofluorescence.

Results

Both diabetic models demonstrated greater infection burden, delayed wound healing, and distinct systemic inflammatory profiles compared with controls. T2DM was characterized by chronically elevated baseline inflammation and a blunted acute response to infection, whereas T1DM exhibited low baseline activity but exaggerated and dysregulated cytokine induction. Semaglutide attenuated infection severity, improved wound integrity, and partially normalized inflammatory patterns. Histology and immunofluorescence corroborated these findings, showing reduced immune cell infiltration and improved tissue organization in semaglutide‐treated cohorts.

Conclusions

T2DM and T1DM are associated with differing inflammatory and immune features in murine spinal implant–associated infection. Metabolic modulation with semaglutide restores immune balance, reduces infection severity, and promotes wound repair. These findings support exploration of GLP‐1RA‐based therapies to improve surgical outcomes in diabetic patients.

Schlagwörter

Stichwörter der Autor:innen

Type 1 diabetes mellitusType 2 diabetes mellituscytokine profileimmune dysregulationmetabolic interventionmurine modelspinal implant‐associated infectionwound healing

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery David Geffen School of Medicine at UCLA Santa Monica California USA.
  • Case Western Reserve University School of Medicine Cleveland Ohio USA.
  • University of California, Los Angeles Los Angeles California USA.
  • Department of Pathology and Laboratory Medicine David Geffen School of Medicine at UCLA Los Angeles California USA.
  • Department of Neurosurgery David Geffen School of Medicine at UCLA Los Angeles California USA.

ORCID-Profile: Thomas E Olson, Nicholas M Bernthal

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Olson, T. E., Lloyd, T. S., Hamad, C. D., Chun, R. F., Wiener, J., Golzar, A., Mehany, J., Shahamatdar, S., Kittredge, A., Pearce, L., Francis, K. P., Obeidin, F., Holly, L. T., Yeaman, M. R., Adams, J. S., Bernthal, N. M., & Sheppard, W. L. (2026). Spinal Implant–Associated Infection in Type 2 and Type 1 Diabetes: Phenotype‐Specific Inflammatory Features and Therapeutic Response to Semaglutide. JOR SPINE, 9(2). https://doi.org/10.1002/jsp2.70196

Vancouver

Olson TE, Lloyd TS, Hamad CD, Chun RF, Wiener J, Golzar A, et al. Spinal Implant–Associated Infection in Type 2 and Type 1 Diabetes: Phenotype‐Specific Inflammatory Features and Therapeutic Response to Semaglutide. JOR SPINE. 2026;9(2). doi:10.1002/jsp2.70196

BibTeX
@article{Olson2026,
  author = {Olson, Thomas E and Lloyd, Trevor S and Hamad, Christopher D and Chun, Rene F and Wiener, Joshua and Golzar, Autreen and Mehany, Joshua and Shahamatdar, Soroush and Kittredge, Andrew and Pearce, Lauren and Francis, Kevin P and Obeidin, Farres and Holly, Langston T and Yeaman, Michael R and Adams, John S and Bernthal, Nicholas M and Sheppard, William L},
  title = {Spinal Implant–Associated Infection in Type 2 and Type 1 Diabetes: Phenotype‐Specific Inflammatory Features and Therapeutic Response to Semaglutide},
  journal = {JOR SPINE},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.1002/jsp2.70196}
}
Kostenlos starten →